Literature DB >> 14723970

Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature.

Riccardo Patacchini1, Alessandro Lecci, Peter Holzer, Carlo Alberto Maggi.   

Abstract

The tachykinin family has recently been extended by the discovery of a third tachykinin gene encoding previously unknown mammalian tachykinins (hemokinin 1, endokinin A and endokinin B) that have a widespread peripheral distribution and a tachykinin NK(1) receptor selectivity. This and the identification of other tachykinin-like peptides such as C14TKL-1 and virokinin raise many questions about the roles played by tachykinins in peripheral tissues and render terms such as 'neurokinins' and 'SP receptor' inappropriate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14723970     DOI: 10.1016/j.tips.2003.11.005

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  16 in total

1.  Role of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways.

Authors:  Iordanes Karagiannides; Kyriaki Bakirtzi; Efi Kokkotou; Dimitris Stavrakis; Kara Gross Margolis; Thomas Thomou; Nino Giorgadze; James L Kirkland; Charalabos Pothoulakis
Journal:  Endocrinology       Date:  2011-10-18       Impact factor: 4.736

2.  Regional variations in neurokinin receptor subtype contributions to muscularis mucosae and epithelial function in rat colon.

Authors:  Caroline B Appleyard; Marangelie Morales; William H Percy
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

Review 3.  Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.

Authors:  Steven D Douglas; Susan E Leeman
Journal:  Ann N Y Acad Sci       Date:  2010-11-22       Impact factor: 5.691

4.  Increase in hemokinin-1 mRNA in the spinal cord during the early phase of a neuropathic pain state.

Authors:  T Matsumura; A Sakai; M Nagano; M Sawada; H Suzuki; M Umino; H Suzuki
Journal:  Br J Pharmacol       Date:  2008-07-28       Impact factor: 8.739

Review 5.  The significance of substance P in physiological and malignant haematopoiesis.

Authors:  Michal Nowicki; Danuta Ostalska-Nowicka; Beata Kondraciuk; Bogdan Miskowiak
Journal:  J Clin Pathol       Date:  2006-12-15       Impact factor: 3.411

6.  Association of genetic variants in tachykinins pathway genes with colorectal cancer risk.

Authors:  Yunxian Yu; Yifeng Pan; Mingjuan Jin; Mingwu Zhang; Shanchun Zhang; Qilong Li; Xia Jiang; Hui Liu; Jing Guo; He Liu; Kun Chen
Journal:  Int J Colorectal Dis       Date:  2012-06-26       Impact factor: 2.571

7.  Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists.

Authors:  A Molinos-Quintana; P Trujillo-Hacha; J I Piruat; J A Bejarano-García; E García-Guerrero; J A Pérez-Simón; Miguel Muñoz
Journal:  Invest New Drugs       Date:  2018-05-02       Impact factor: 3.850

8.  Autocrine regulation of human sperm motility by tachykinins.

Authors:  Francisco M Pinto; Cristina G Ravina; Nerea Subiran; Antonio Cejudo-Román; Manuel Fernández-Sánchez; Jon Irazusta; Nicolas Garrido; Luz Candenas
Journal:  Reprod Biol Endocrinol       Date:  2010-08-26       Impact factor: 5.211

9.  Mouse Hemokinin-1 Decapeptide Subjected to a Brain-specific Post-translational Modification.

Authors:  Georgia Deliconstantinos; Stephen Barton; Mikhail Soloviev; Nigel Page
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

10.  Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12.

Authors:  Brian M Janelsins; Tina L Sumpter; Olga A Tkacheva; Darling M Rojas-Canales; Geza Erdos; Alicia R Mathers; William J Shufesky; Walter J Storkus; Louis D Falo; Adrian E Morelli; Adriana T Larregina
Journal:  Blood       Date:  2013-01-30       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.